Logo image of KOVO.CA

KOVO+ HOLDINGS INC (KOVO.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:KOVO - CA5007421012 - Common Stock

0.035 CAD
0 (0%)
Last: 1/15/2026, 7:00:00 PM
Fundamental Rating

1

Overall KOVO gets a fundamental rating of 1 out of 10. We evaluated KOVO against 9 industry peers in the Health Care Technology industry. KOVO may be in some trouble as it scores bad on both profitability and health. KOVO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • KOVO had negative earnings in the past year.
  • KOVO had a negative operating cash flow in the past year.
KOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFKOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • KOVO has a better Return On Assets (-43.18%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -43.18%
ROE N/A
ROIC N/A
ROA(3y)-35.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KOVO.CA Yearly ROA, ROE, ROICKOVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KOVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KOVO.CA Yearly Profit, Operating, Gross MarginsKOVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -10 -20 -30 -40 -50

More info and screens

0

2. Health

2.1 Basic Checks

  • KOVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • KOVO has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for KOVO is higher compared to a year ago.
KOVO.CA Yearly Shares OutstandingKOVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
KOVO.CA Yearly Total Debt VS Total AssetsKOVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -3.17, we must say that KOVO is in the distress zone and has some risk of bankruptcy.
  • KOVO has a Altman-Z score (-3.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.17
ROIC/WACCN/A
WACC7.04%
KOVO.CA Yearly LT Debt VS Equity VS FCFKOVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

  • A Current Ratio of 0.07 indicates that KOVO may have some problems paying its short term obligations.
  • The Current ratio of KOVO (0.07) is worse than 77.78% of its industry peers.
  • KOVO has a Quick Ratio of 0.07. This is a bad value and indicates that KOVO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.07, KOVO is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
KOVO.CA Yearly Current Assets VS Current LiabilitesKOVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

  • KOVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.03%, which is quite impressive.
  • The Revenue has been growing slightly by 3.54% in the past year.
  • The Revenue has been growing by 21.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)58.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.9%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y21.39%
Revenue growth 5YN/A
Sales Q2Q%3.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KOVO.CA Yearly Revenue VS EstimatesKOVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KOVO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KOVO.CA Price Earnings VS Forward Price EarningsKOVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KOVO.CA Per share dataKOVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for KOVO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KOVO+ HOLDINGS INC

TSX-V:KOVO (1/15/2026, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-28
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners73.89%
Ins Owner ChangeN/A
Market Cap6.19M
Revenue(TTM)10.81M
Net Income(TTM)-6.36M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.08
BVpS-0.06
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.29%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -3.17
F-Score3
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)41.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y21.39%
Revenue growth 5YN/A
Sales Q2Q%3.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-455.65%
OCF growth 3YN/A
OCF growth 5YN/A

KOVO+ HOLDINGS INC / KOVO.CA FAQ

Can you provide the ChartMill fundamental rating for KOVO+ HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to KOVO.CA.


What is the valuation status of KOVO+ HOLDINGS INC (KOVO.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to KOVO+ HOLDINGS INC (KOVO.CA). This can be considered as Overvalued.


Can you provide the profitability details for KOVO+ HOLDINGS INC?

KOVO+ HOLDINGS INC (KOVO.CA) has a profitability rating of 1 / 10.


How financially healthy is KOVO+ HOLDINGS INC?

The financial health rating of KOVO+ HOLDINGS INC (KOVO.CA) is 0 / 10.